Recurrent transient ischemic attacks in a 15-year-old boy with β-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis

Acta Neurologica Belgica

Volumn 103, Issue 2, 2003, Pages 99-102

  Engelborghs, Sebastiaan ^a,b   Pickut, Barbara A ^a,b   De Deyn, Peter P ^a,b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

SPECT; Stroke; Thalassemia; Thrombophilia; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CYSTEINE ETHYL ESTER TC 99M; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ARTICLE; BETA THALASSEMIA; BRAIN PERFUSION; CASE REPORT; COMORBIDITY; GENE MUTATION; HEMOGLOBINOPATHY; HETEROZYGOSITY; HUMAN; MALE; MEDICAL DOCUMENTATION; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SYMPTOMATOLOGY; THALASSEMIA MINOR; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOPHILIA; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 0037898105     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Albucher J. F., Guiraud Chaumeil B., Chollet F., Cadroy Y., Sie P. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke. Stroke, 1996, 27: 766-777.
2. Becker S., Heller C., Gropp F., Scharrer I., Kreuz W. Thrombophilic disorders in children with cerebral infarction. Lancet, 1998, 352: 1756-1757.
3. Giordano P., Del Vecchio G. C., Altomare M., Copppola B., Schettini F. et al. Resistance to activated protein C in thalassaemic patients: an underlying cause to thrombosis. Eur. J. Haematol., 1998, 61: 123-127.
4. Giordano P., Sabato V., Schettini F., De Mattia D., Iolascon A. Resistance to acitivated protein C as a risk factor of stroke in a thalassemic patient. Haematologica, 1997, 82: 698-700.
5. Kenet G., Sadetzki S., Murad H., Martinowitz U., Rosenberg N. et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke, 2000, 31: 1283-1288.
6. Lalouschek W., Mannhalter C. The prothrombin G20210A mutation and factor V Leiden mutation in patients with cerebrovascular disease. Blood, 1998, 92: 704-705.
7. Laloux P. SPECT imaging in transient ischaemic attacks and subarachnoid haemorrhage. In: A textbook of SPECT in neurology and psychiatry. De Deyn P. P., Dierckx R. A., Alavi A., Pickut B. A. (eds.). London, John Libbey, 1997, 323-334.
8. Powars D. R., Conti P. S., Wong W. Y, Groncy P., Hyman C. et al. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood, 1999, 93: 71-79.
9. Ridker P. M., Hennekens C. H., Lindpainter K., Stampfer M. J., Eisenberg P. R. et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N. Engl. J. Med., 1995, 332: 912-917.
10. Rosendaal F. R., Siscovick D. S., Schwartz S. M., Berverly R. K., Psaty B. M. et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood, 1997, 89: 2817-2821.
11. Shirahata A., Funahara Y., Opartkiattikul N., Fucharoen S., Laosombat V. et al. Protein C and protein S deficiency in thalassemic patients. The Southeast Asian J. Trop. Med. Public Health, 1992, 23 (suppl. 2): 65-73.